Automated diagnosis of obstructive sleep apnea using a wearable device
North West London Pebble Pathway: Automated OSA Diagnosis
This study is testing a new wearable device to see if it can quickly and easily diagnose obstructive sleep apnea at home, making the process simpler and cheaper for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Imperial College London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06507228 on ClinicalTrials.gov |
What this trial studies
This study investigates a novel straight-to-test clinical diagnostic pathway for obstructive sleep apnea (OSA) using the AcuPebble, a wearable acoustic sensor designed for at-home diagnosis. Patients referred for OSA testing from primary care will be triaged onto this pathway, which aims to reduce the time and costs associated with traditional diagnostic methods. The study will compare outcomes such as time-to-diagnosis and cost savings against a historical cohort using conventional testing. The goal is to provide a more efficient, accessible, and patient-friendly approach to diagnosing OSA.
Who should consider this trial
Good fit: Ideal candidates are patients referred from primary care for obstructive sleep apnea testing.
Not a fit: Patients who are unable to follow test instructions will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce waiting times and costs for OSA diagnosis, leading to earlier treatment and improved patient outcomes.
How similar studies have performed: Other studies have shown promise with similar automated diagnostic approaches, indicating potential for success in this novel pathway.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * OSA testing referral from primary care Exclusion Criteria: * Unable to follow test instructions
Where this trial is running
London
- Charing Cross Hospital — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Patrik Bachtiger
- Email: p.bachtiger@imperial.ac.uk
- Phone: 07814396222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.